WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman Sachs

Mylan sold a ₹1,839 crore stake in Biocon through a block deal, attracting strong institutional demand. ICICI Prudential Mutual Fund emerged as the largest buyer, alongside other mutual funds, insurers and foreign investors, highlighting continued confidence in the pharmaceutical company.

Raccontata dathehindubusinessline.comeconomictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
economictimes.indiatimes.comStai leggendo1 g fa

Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman Sachs

Mylan sold a ₹1,839 crore stake in Biocon through a block deal, attracting strong institutional demand. ICICI Prudential Mutual Fund emerged as the largest buyer, alongside other mutual funds, insurers and foreign…

originale
thehindubusinessline.com1 g fa

Mylan exits Biocon with ₹3,679-crore stake sale; Biocon shares jump over 6%

Mylan, part of Viatris, exits Biocon by selling its 5.64% stake for ₹3,679 crore. Domestic mutual funds and global investors buy shares as Biocon gains over 6%.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 13 luglio 2026·thehindubusinessline.com

    Biocon to see block deals, as Viatris plans to exit

    Viatris plans to sell a 5.64% stake in Biocon at a 7.9% discount, marking a complete exit.

  2. martedì 14 luglio 2026·economictimes.indiatimes.com

    Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

    Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale…

  3. martedì 14 luglio 2026·economictimes.indiatimes.com

    Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman Sachs

    Mylan sold a ₹1,839 crore stake in Biocon through a block deal, attracting strong institutional demand. ICICI Prudential Mutual Fund emerged as the largest buyer, alongside other…

  4. martedì 14 luglio 2026·thehindubusinessline.com

    Mylan exits Biocon with ₹3,679-crore stake sale; Biocon shares jump over 6%

    Mylan, part of Viatris, exits Biocon by selling its 5.64% stake for ₹3,679 crore. Domestic mutual funds and global investors buy shares as Biocon gains over 6%.